Patterson-UTI
PTEN
359 hedge funds and large institutions have $4.34B invested in Patterson-UTI in 2023 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 122 increasing their positions, 126 reducing their positions, and 57 closing their positions.
7% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 57
0.93% more ownership
Funds ownership: 95.26% → 96.19% (+0.93%)
1% more funds holding
Funds holding: 357 → 359 (+2)
3% less repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 126
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
21% less capital invested
Capital invested by funds: $5.48B → $4.34B (-$1.14B)
90% less call options, than puts
Call options by funds: $16.6M | Put options by funds: $170M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$92.9M |
| 2 |
Blackstone Inc
New York
|
-$75.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$48.2M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$40.8M |
| 5 |
ACM
Anomaly Capital Management
New York
|
-$40.2M |
PTEN Hedge Fund Activity: Q4 2023 in Review
359 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Patterson-UTI (PTEN) for Q4 2023, worth a combined $4.34B — down 21% from $5.48B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new PTEN positions and 57 closed out — a net gain of 4 holders — while 122 added to existing stakes and 126 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $94.7M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $92.9M sold.
- 359 institutional investors held Patterson-UTI (PTEN) as of Q4 2023, up from 357 in Q3 2023.
- Funds reported $4.34B of Patterson-UTI stock for Q4 2023, down 21% quarter-over-quarter.
- 61 funds opened new Patterson-UTI positions in Q4 2023 and 57 closed out, a net change of +4 holders.
- The largest Patterson-UTI buyer in Q4 2023 was Morgan Stanley, an estimated $94.7M added.
- The largest Patterson-UTI seller in Q4 2023 was T. Rowe Price Investment Management, an estimated $92.9M sold.
Based on aggregated 13F filings for Q4 2023.